Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/12/1996WO1996039166A1 Analogs of botulinum toxin and pharmaceutical compositions of botulinum toxin
12/12/1996WO1996039165A1 Peptides and compounds that bind to the il-1 receptor
12/12/1996WO1996039164A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
12/12/1996WO1996039163A1 Aminopeptidase p inhibitors and uses thereof
12/12/1996WO1996039162A1 Regulation of eating behavior
12/12/1996WO1996039161A1 Multi-tyrosinated somatostatin analogs
12/12/1996WO1996039160A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
12/12/1996WO1996039159A1 Collagen-based delivery matrix
12/12/1996WO1996039158A1 Pineal gland specific gene-1
12/12/1996WO1996039141A1 Methods for minimizing bone loss
12/12/1996WO1996039128A1 Protein particles for therapeutic and diagnostic use
12/12/1996WO1996039125A1 Composition and method for administration of bio-affecting catalysts
12/12/1996WO1996039098A1 A device for delivering a preselected molecule into the system circulation
12/12/1996WO1996035788A3 Kunitz type protease inhibitors
12/12/1996WO1996035785A3 Transgenic animals having a defective thyroid hormone receptor beta gene
12/12/1996WO1996034010A3 Inhibitors of farnesyl-protein transferase
12/12/1996WO1996033730A3 Chemokine binding protein and methods of use therefor
12/12/1996WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
12/12/1996WO1996020732A3 Non-traumatic administration of gene delivery vehicles
12/12/1996WO1996018733A3 Ribozyme-mediated inactivation of leukemia-associated rna
12/12/1996WO1996011951A3 Keratinocyte growth factor analogs
12/12/1996WO1996011949A3 Analogs of keratinocyte growth factor
12/12/1996WO1996011266A3 Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein
12/12/1996DE19530273C1 Monoclonal antibodies specific for cell-surface glyco-protein MGC-24
12/12/1996CA2562211A1 Human g-protein chemokine receptor hdgnr10
12/12/1996CA2413012A1 Human vascular endothelial growth factor 2
12/12/1996CA2226438A1 Oligonucleotides specific for hepatitis c virus
12/12/1996CA2226429A1 Aminopeptidase p inhibitors and uses thereof
12/12/1996CA2224176A1 Gene transfer for treating a connective tissue of a mammalian host
12/12/1996CA2224094A1 Human amine receptor
12/12/1996CA2224002A1 Human vascular endothelial growth factor 3
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223888A1 Human cystatin e
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223707A1 Novel gene-up regulated in regenerating liver
12/12/1996CA2223492A1 Isolation of mammalian hematopoietic stem cells
12/12/1996CA2223421A1 Methods for enhancement of protective immune responses
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2223177A1 Method for increasing hdl cholesterol level
12/12/1996CA2223174A1 Methods for minimizing bone loss
12/12/1996CA2223153A1 Regulation of eating behavior
12/12/1996CA2223038A1 A c5a-like seven transmembrane receptor
12/12/1996CA2222962A1 Multi-tyrosinated somatostatin analogs
12/12/1996CA2222939A1 Peptides and compounds that bind to the il-1 receptor
12/12/1996CA2222322A1 Quinolizinone type compounds
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2222060A1 Method for rapid enzymatic alcohol removal
12/12/1996CA2221798A1 Colon specific genes and proteins
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221684A1 Novel cathepsin and methods and compositions for inhibition thereof
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221616A1 Human g-protein receptor hibef51
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2221258A1 Use of neuro-derived fetal cell lines for transplantation therapy
12/12/1996CA2221116A1 G-protein parathyroid hormone receptor hltdg74
12/12/1996CA2220979A1 Human g-protein receptor hpraj70
12/12/1996CA2220978A1 Human g-protein coupled receptor (hetgq23)
12/12/1996CA2220912A1 Human ccn-like growth factor
12/12/1996CA2220895A1 Protein particles for therapeutic and diagnostic use
12/12/1996CA2220336A1 Therapy using lymphotoxin and thrombopoietin
12/12/1996CA2220146A1 Modification of polypeptide drugs to increase electrotransport flux
12/12/1996CA2220130A1 Kunitz type plasma kallikrein inhibitors
12/12/1996CA2220060A1 A method for increasing the electrotransport flux of polypeptides
12/12/1996CA2218329A1 Fibroblast growth factor-11
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/12/1996CA2217229A1 Pineal gland specific gene-1
12/12/1996CA2217216A1 Human chemokine beta-13
12/12/1996CA2212992A1 Fibroblast growth factor-14
12/12/1996CA2196281A1 Dual carrier immunogenic construct
12/11/1996EP0747482A2 Hepatitis GB virus recombinant proteins and uses thereof
12/11/1996EP0747481A1 Epstein-Barr virus peptides and antibodies against these peptides
12/11/1996EP0747480A1 Oligonucleotides specific for cytokine signal transducer gp130 mRNA
12/11/1996EP0747477A1 Strain of trichoderma harzieanum rifai, process for obtaining l-lysine-alpha-oxidase as an inhibitor of viral and bacterial activity, immunomodulator and skin healing agent
12/11/1996EP0747395A1 Composition for treating renal failure
12/11/1996EP0747394A2 Hepatitis GB virus synthetic peptides and uses thereof
12/11/1996EP0747393A1 Thiazolo benzazepine containing dual action inhibitors
12/11/1996EP0747392A1 1,2-Diazepine containing dual action inhibitors
12/11/1996EP0747390A2 Reducing gelation of a fatty acid acylated protein using a citrate buffer
12/11/1996EP0747386A2 Method and antisense oligonucleotides to Interleukin-6 receptor mRNA for inhibiting cellular proliferation
12/11/1996EP0747066A2 Biocompatible adhesive compositions
12/11/1996EP0747060A2 Anti-plasma-antibody-preparation
12/11/1996EP0747059A1 Anti-inflammatory containing monoclonal antibodies having reactivity with sialyl-lewis x sugar chains originating in hemangioendothelial cell membrane
12/11/1996EP0747056A2 Methods for minimizing bone loss
12/11/1996EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
12/11/1996EP0747033A1 Transfusion liquid-containing holder and prepared transfusion liquid
12/11/1996EP0746624A1 Vector for liver-specific gene therapy
12/11/1996EP0746619A1 Human phosphodiesterase type ivc, and its production and use
12/11/1996EP0746614A1 Method and reagent for inhibiting the expression of disease related genes
12/11/1996EP0746612A1 Synthetic polynucleotides
12/11/1996EP0746609A1 Transgenic non-human animals capable of producing heterologous antibodies
12/11/1996EP0746605A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
12/11/1996EP0746568A1 Method for the preparation of glycopeptidic antibiotic precursors by intramolecular cyclisation and formation of a biaryl ether bridge and novel compounds so obtained
12/11/1996EP0746567A1 Novel opioid peptides for the treatment of pain and use thereof
12/11/1996EP0746566A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/11/1996EP0746565A1 Novel bombesin-related peptides
12/11/1996EP0746343A1 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE $i(IN VIVO) OR $i(EX VIVO)
12/11/1996EP0746337A1 Verotoxin pharmaceutical compositions and medical treatments therewith
12/11/1996EP0746335A1 Medical application of bromelain
1 ... 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 ... 3163